|
|
|
Volumn 22, Issue 2, 2005, Pages 87-90
|
|
The effect of a nationwide antibiotic restriction policy on antibiotic usage in a stem cell transplantation unit
a
|
|
Author keywords
Antibiotic; Restriction policy; Stem cell transplantation
|
|
Indexed keywords
ACICLOVIR;
AMIKACIN;
AMOXICILLIN;
AMOXICILLIN PLUS CLAVULANIC ACID;
AMPHOTERICIN B;
AMPICILLIN;
ANTIBIOTIC AGENT;
AZLOCILLIN;
AZTREONAM;
CEFAZOLIN;
CEFOXITIN;
CEFUROXIME;
CHLORAMPHENICOL;
CLARITHROMYCIN;
CLINDAMYCIN;
FAMCICLOVIR;
FLUCONAZOLE;
LAMIVUDINE;
METRONIDAZOLE;
NAFCILLIN;
ORNIDAZOLE;
PENICILLIN G;
RIBAVIRIN;
RIFABUTIN;
RIFAMPICIN;
STREPTOMYCIN;
SULTAMICILLIN;
TUBERCULOSTATIC AGENT;
UNINDEXED DRUG;
VALACICLOVIR;
ADULT;
ALLOGENEIC STEM CELL TRANSPLANTATION;
ALLOGENIC BONE MARROW TRANSPLANTATION;
ANTIBIOTIC THERAPY;
ARTICLE;
AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG USE;
FOLLOW UP;
HEALTH CARE FACILITY;
HEALTH CARE POLICY;
HEALTH PROGRAM;
HEMATOLOGY;
HUMAN;
MEDICAL SPECIALIST;
PRACTICE GUIDELINE;
STEM CELL TRANSPLANTATION;
|
|
EID: 22644443874
PISSN: 13007777
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (6)
|
